Literature DB >> 7213699

Steps in the biosynthesis of mosquito cell membrane glycoproteins and the effects of tunicamycin.

T D Butters, R C Hughes, P Vischer.   

Abstract

A cultured cell line of the mosquito, Aedes aegypti, is sensitive to tunicamycin as expected from the ability of crude membrane preparations to catalyse the formation of N-acetylglucosamine-linked dolichyl pyrophosphate. Formation of dolichylphosphomannose was also detected and this reaction was totally insensitive to tunicamycin. Incorporation of radioactive mannose into total acid-precipitable glycoproteins was inhibited greater than 90% in whole cells by tunicamycin, while the incorporation of leucine and glucosamine was less affected. Separation of the radioactive hexosamines from acid hydrolysates of cells incubated with [14C]glucosamine and tunicamycin showed predominant labelling of galactosamine, whereas in control cells not treated with the drug both glucosamine and galactosamine were labelled equally. Evidently, mosquito cells synthesise N-glycosidically linked carbohydrate chains assembled through tunicamycin-sensitive steps involving dolichyl pyrophospho-oligosaccharides, and O-glycosidically linked chains rich in N-acetylgalactosamine, the assembly of which is unaffected by tunicamycin. These results support structural evidence (Butters, T.D. and Hughes, R.C. (1981) Biochim. Biophys. Acta 640, 655-671) for the presence of high mannose N-glycans and N-acetylgalactosamine-rich O-glycans in mosquito cell glycoproteins. The absence of complex N-glycans was confirmed by the demonstration of negligible activities of N-acetylglucosaminyl-, galactosyl- and sialyltransferases responsible for assembly of the terminal sequences of N-glycans of mature mammalian glycoproteins.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7213699     DOI: 10.1016/0005-2736(81)90097-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  42 in total

1.  Improved glycosylation of a foreign protein by Tn-5B1-4 cells engineered to express mammalian glycosyltransferases.

Authors:  K Breitbach; D L Jarvis
Journal:  Biotechnol Bioeng       Date:  2001-08-05       Impact factor: 4.530

2.  Novel baculovirus expression vectors that provide sialylation of recombinant glycoproteins in lepidopteran insect cells.

Authors:  D L Jarvis; D Howe; J J Aumiller
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  A transgenic insect cell line engineered to produce CMP-sialic acid and sialylated glycoproteins.

Authors:  Jared J Aumiller; Jason R Hollister; Donald L Jarvis
Journal:  Glycobiology       Date:  2003-02-20       Impact factor: 4.313

4.  Expression and functional characterization of a nucleotide sugar transporter from Drosophila melanogaster: relevance to protein glycosylation in insect cell expression systems.

Authors:  Jared J Aumiller; Donald L Jarvis
Journal:  Protein Expr Purif       Date:  2002-12       Impact factor: 1.650

5.  Cell-surface glycoconjugate diversity among lepidopteran cell lines.

Authors:  W J McCarthy; K A Fletcher
Journal:  In Vitro Cell Dev Biol       Date:  1992 Nov-Dec

6.  Post-translational modifications in insect cells.

Authors:  H D Klenk
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

Review 7.  Expression of eukaryotic genes in insect cultures.

Authors:  M J Fraser
Journal:  In Vitro Cell Dev Biol       Date:  1989-03

Review 8.  Protein N-glycosylation in the baculovirus-insect cell system.

Authors:  Xianzong Shi; Donald L Jarvis
Journal:  Curr Drug Targets       Date:  2007-10       Impact factor: 3.465

9.  Site-specific glycosylation of the human cytomegalovirus tegument basic phosphoprotein (UL32) at serine 921 and serine 952.

Authors:  K D Greis; W Gibson; G W Hart
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Role of N-linked glycosylation for sindbis virus infection and replication in vertebrate and invertebrate systems.

Authors:  Ronald L Knight; Kimberly L W Schultz; Rebekah J Kent; Meera Venkatesan; Diane E Griffin
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.